1.. Introduction   {#sec1}
==================

Since the mid-1990s, peer-reviewed journals and the crystallographic community have worked towards the notion that crystallographic models and the associated diffraction data should be submitted to the Protein Data Bank (Baker *et al.*, 1996[@bb1]) and publicly released upon publication (Wlodawer *et al.*, 1998[@bb8]; Editorial, 1998[@bb7]; Baker & Saenger, 1999[@bb2]). This is nowadays the norm, and deviations from that rule are rare. As much as 99.8% of crystallographic structures submitted to the PDB within 2011--2013 make available both the model and the experimental data. This also enables critical re-evaluation of submitted models, based on the original diffraction data but in the light of improved methods and software (Joosten *et al.*, 2009[@bb4]). However, the time frame for data submission has been less well defined: should data be available in one of the wwPDB (Berman *et al.*, 2003[@bb3]) sites before the paper is submitted, before it is accepted for publication, or merely after the paper is accepted, just before publication?

Recently, a Validation Task Force assigned by the PDB has published a recommendation (Read *et al.*, 2011[@bb6]) that the submission of papers that report on crystallographic data should be accompanied by a validation report issued from the PDB. It is an obvious pre­requisite that both the experimental data and the model coordinates are submitted to the PDB before paper submission, to achieve this. Such reports are indispensable tools for technical review of the paper by the assigned referees (Read *et al.*, 2011[@bb6]), and crucial for ensuring that any claims based on the structure are supported by data of appropriate quality.

2.. Materials and methods   {#sec2}
===========================

The original data presented in this paper are available in public databases (PDB and PubMed); a data digest relevant to our conclusions are included as Supplementary Material;[1](#fn1){ref-type="fn"} and all the code and the database as well as minimal instructions to reproduce all the results have been uploaded to GitHub, at the repository <https://github.com/massyah/PdbMine>.

Briefly, the identifier of PDB records with associated 'Primary citation' were retrieved from the RCSB webserver on 28 June 2013 at 15:25 GMT+1 (91 738 unique IDs). The corresponding PDB entries were downloaded from the ftp.wwpdb.org FTP server, parsed, and the PDB fields relevant for this study (namely PDB ID, date of deposition, associated PubMed ID) were stored in a SQLITE3 database. The PubMed entries of all associated citations were downloaded from the PubMed web server using the *EUTILS* suite and then parsed and stored in the SQLITE3 database. From the PubMed associated MEDLINE records, we extracted (if available) the following dates: received, revised, accepted and ahead of print date from the publication history (PHST) field; date of publication (DP); date created (DA); PubMed central release date (PMCR); date of electronic publication (DEP) and Entrez Date (EDAT). The 'earliest public date' is then defined as the earliest of the PubMed dates; while the 'earliest publication date' is defined as the earliest of the DP, EDAT, DA, DEP and the 'ahead of print', 'accepted' dates from the PHST. We then considered for this analysis the inner join of the PDB entries table with the PubMed table, where we only kept entries for which (i) the earliest public date was after 1 January 1995; (ii) the published date and accepted date were before 1 January 2014 or available; and (iii) either the publication history was available or the received date was earlier than the accepted or published date; totalling 69 026 unique PDB entries joined with 35 924 unique PubMed entries.

All entries were considered to be 'on time' by default. We defined as 'deposited after acceptance' those entries for which the date of deposition with the PDB was more than two days after the 'earliest publication date'. We identified as 'deposited after submission' those entries that were not 'deposited after acceptance' but for which deposition with the PDB was more than two days after the 'earliest public date'. The impact-factor estimates used to build Table 1[▶](#table1){ref-type="table"} originate from the Thomsom Reuters Journal Citation Reports Science Edition 2011 (<http://thomsonreuters.com/journal-citation-reports/>).

3.. Results and discussion   {#sec3}
============================

3.1.. Correlating the dates of crystallographic structure and data submission to the PDB and of manuscript submission for peer review   {#sec3.1}
---------------------------------------------------------------------------------------------------------------------------------------

The results from the analysis of the PDB deposition date against the submission and acceptance dates were manually curated to select journals with at least 100 publications that referred to PDB entries over the last 12 years, and are presented in Table 1[▶](#table1){ref-type="table"}. The number of structures submitted to the PDB only after the paper was accepted for publication has historically been rather low (less than 10% since 1999) and has been minimized over the years, being just 3.4% (205 of 6003 papers) in 2012 (Fig. 1[▶](#fig1){ref-type="fig"}). However, the number of structures submitted to the PDB after the paper has been submitted for review is, somewhat surprisingly, high. Although tracing the submission date is not possible for all publications, we were able to extract that information for about 50% of the structures published in 2012, and about one third of them were deposited after the paper was submitted to the journal for peer review. It is also noteworthy, that a quarter of the depositions in the window between manuscript submission and manuscript acceptance occurred just within the last six days before manuscript acceptance (Supplementary Fig. S1). It is unlikely that referees had access to PDB validation reports in that time window, and more likely that formal acceptance of the manuscript was postponed until the structure was deposited.

3.2.. Confidentiality *versus* transparency issues   {#sec3.2}
----------------------------------------------------

Many authors are worried that submission of a structure to the PDB will trigger competitors to accelerate their own paper submission. This is a legitimate concern, and having been at the receiving end of this practice, this is not a pleasant experience. However, this concern is ameliorated by an existing submission-time option where the sequences corresponding to the submitted structures are not made publically available before the entry is finally released. The possibility of not directly disclosing the sequence is popular: it is currently used by about two thirds of entries awaiting release. A submission-time option to also withhold the title, currently only possible upon request, would undoubtedly prove equally popular and could help removing remaining concerns.

3.3.. Some journals are more equal than others   {#sec3.3}
------------------------------------------------

Urban legend has it that high-impact journals are notorious for tolerating late submission as they typically publish 'hot' structures, which many research groups are competing to be the first to determine: to paraphrase a well known quotation (Orwell, 1945[@bb5]), all journals are equal, but some journals are more equal than others. Indeed, we find that journals with a high impact factor for which we could trace the full publication history (the list most regrettably does not include important journals like *Science*, *Proc. Natl Acad. Sci. USA* and *J. Biol. Chem.*, which do not make the complete publication history available in the PubMed/MEDLINE records) are more likely to tolerate late submission of crystallographic data (Supplementary Fig. S2). A notable exception to this rule is *Acta Crystallographica Section D*, which traditionally had a significantly lower impact factor (between 1 and 3) and has only shot to impact-factor prominence over the last couple of years (mainly owing to the publication of highly cited methodological papers). One of the best performing journals in recent years is *Proteins*, which unsurprisingly has a simple, clear and short policy statement in the instruction for authors: 'For all crystallographic studies, coordinates and structure factors should be deposited in the Protein Data Bank at the time of manuscript submission'. This policy, unlike others (a survey of the policies of different journals is available as Supplementary Table S1) is explicit about the timing of deposition. Clarity about policies is crucial, but ensuring that the policies are honored is key.

4.. Conclusion   {#sec4}
================

As we are confident that all journals strive for transparency in the publication procedure and for rigor in the reported results, we strongly advocate that the editorial teams improve the clarity of their policies, and enforce these effectively. The structural biologists, authors and reviewers alike, should also share the responsibility for following these policies. As a community we must strive to ensure that coordinates and experimental data for macromolecular models are submitted to the PDB at the same time as the paper is submitted for review. Only then will validation reports also become available to the referees as part of the necessary material for peer review.
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###### Numbers and percentages of papers for which the associated PDB entries were submitted after the submission date or after the acceptance or publication date, per journal and associated journal impact factors (IF), for journals for which data were available for more than 100 structures for the period between 2000 and 2012

                                                   Deposition date with PDB after                   
  ---------------------------------- ------ ------ -------------------------------- ---- ----- ---- ------
  *J. Mol. Biol.*                    8885   5467   1074                             20   622   7    4.0
  *Structure*                        3501   2045   813                              40   408   12   6.3
  *Acta Cryst. D*                    2688   2310   545                              24   154   6    12.6
  *Nature Struct. Mol. Biol.*        2525   1445   864                              60   226   9    12.7
  *Nature (London)*                  1966   1476   1020                             69   244   12   36.2
  *Protein Sci.*                     1907   215    18                               8    103   5    2.8
  *EMBO J.*                          1826   1061   543                              51   228   12   9.2
  *Proteins*                         1588   166    9                                5    28    2    3.3
  *Bioorg. Med. Chem. Lett.*         1348   1299   732                              56   93    7    2.5
  *Cell*                             1147   711    471                              66   138   12   32.4
  *Mol. Cell*                        1084   788    554                              70   115   11   14.2
  *PLoS One*                         779    779    146                              19   42    5    4.1
  *Acta Cryst. F*                    665    665    60                               9    30    5    0.5
  *Biochem. J.*                      590    61     21                               34   41    7    4.9
  *FEBS J.*                          549    42     3                                7    19    3    3.8
  *J. Struct. Biol.*                 537    495    75                               15   35    7    3.4
  *Biochem. Biophys. Res. Commun*.   484    417    18                               4    51    11   2.5
  *FEBS Lett.*                       469    302    51                               17   81    17   3.5
  *Chem. Biol.*                      461    338    114                              34   120   26   5.8
  *Angew. Chem. Int. Ed. Engl.*      353    128    43                               34   20    6    13.5
  *Nature Chem. Biol.*               351    348    184                              53   28    8    14.7
  *Biochim. Biophys. Acta*           331    277    46                               17   21    6    3.6
  *PLoS Pathog.*                     262    262    89                               34   39    15   9.1
  *Bioorg. Med. Chem.*               254    239    48                               20   26    10   2.6
  *Chembiochem*                      242    106    16                               15   8     3    3.9
  *J. Biol. Inorg. Chem.*            203    171    37                               22   17    8    3.3
  *Biophys. J.*                      196    51     7                                14   22    11   3.6
  *PLoS Biol.*                       185    185    84                               45   18    10   11.5
  *J. Biomol. NMR*                   181    87     12                               14   28    15   3.6
  *BMC Struct. Biol.*                176    176    34                               19   7     4    2.5
  *Arch. Biochem. Biophys.*          167    142    16                               11   7     4    2.9
  *ChemMedChem*                      158    74     6                                8    2     1    3.2
  *EMBO Rep.*                        153    147    67                               46   22    14   7.4
  *Immunity*                         150    94     30                               32   20    37   21.6
  *J. Struct. Funct. Genomics*       131    115    6                                5    5     1    n/a
  *Nature Commun.*                   119    119    59                               50   50    2    7.3
  *J. Inorg. Biochem.*               101    79     20                               25   20    6    3.0

Or publication, if the submission date is not available.
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